CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Rubino Alan L Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise | +13,888 | $7.20 | $100K | 209,195 |
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise | +6,002 | $16.66 | $100K | 215,197 |
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise | +5,555 | $18.00 | $100K | 220,752 |
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) | +13,888 | 279,307 | ||
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) | +6,002 | 303,998 | ||
| 2024-04-30 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) | +5,555 | 219,445 | ||
| 2024-04-18 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 212,807 |
| 2024-04-18 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $44.59 | $780K | 195,307 |
| 2024-04-18 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 245,000 | ||
| 2024-04-17 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 212,807 |
| 2024-04-17 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $46.47 | $813K | 195,307 |
| 2024-04-17 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 262,500 | ||
| 2024-04-09 | Rubino Alan L Director | Option exercise | +3,000 | $4.12 | $12K | 20,594 |
| 2024-04-09 | Rubino Alan L Director | Option exercise · Stock Option (Right to Buy) | +3,000 | 0 | ||
| 2024-03-27 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +3,278 | $3.74 | $12K | 26,673 |
| 2024-03-27 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −3,278 | $51.57 | $169K | 23,395 |
| 2024-03-27 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +3,278 | 0 | ||
| 2024-03-14 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 212,370 |
| 2024-03-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $44.02 | $770K | 194,870 |
Page 28 of 75 · 1,497 trades